Skip to main content
Validraft

Pricing / Scope desk

More affordable than you think.

Validraft research and candidate backtests start at $79. The declared run determines the question we can answer and the report we can issue; price then moves only with run complexity, data depth, data volume, or documented external costs.

01

One $79 base

Research and one-shot candidate scopes start at the same price for every client.

02

Run fixes the report

Research, development, final validation, and diagnostics have different evidence boundaries.

03

Same review discipline

Price never buys a more favourable verdict or a lower quality review.

Interactive estimator

Choose the run. Get the right report.

One price model for every client. Research, candidate development, final validation, and diagnostics answer different questions; the declared run fixes the evidence boundary and report.

01 / Run type and report

02 / Data depth and quality

03 / Data volume

01Run & report
02Data depth
03Data volume

Estimate logic

Three price inputs. One declared purpose.

The estimator is deliberately a range. Exact rules, run intent, coverage, licensing, and compute are confirmed before the quote becomes binding.

01Run & reportMaps the question to research, candidate development, final validation, or a diagnostic review.
02Data depthCaptures frequency, point-in-time joins, text, order book, normalization, and sourcing.
03Data volumeMoves coverage QA, storage, and compute with the number of instruments.

Run & report catalogue

The deliverable follows the run—not the spend.

These are distinct scientific products. Parameter optimization remains candidate development; only a separate strict validation of a frozen candidate can issue a final validation report. Catalogue prices show the run component before data-depth and universe adjustments.

01

research_only

Research study

From $79

Research Report

research_report.pdf

Signal, feature, event, IC/ICIR, or regime research before a tradable candidate has been frozen.

Research evidence only: no validated equity curve, final GO decision, or promotion claim.

02

candidate_backtest

Candidate backtest

$79–$299

Backtest Development Report

backtest_development_report.pdf

One-shot testing or pre-declared parameter optimization used to develop and select a candidate.

Candidate evidence only. Optimization does not validate the selected winner; it must be frozen before validation.

03

validation

Final validation

$179–$249

Final Validation Report

final_report.pdf

Strict governed validation of one frozen candidate, with protected OOS or lockbox evidence and same-freeze stress review.

The only path that can produce a promotion-grade decision. Candidate and supported data-domain prerequisites apply.

04

stress / portfolio / revalidation

Diagnostic review

$79–$199

Diagnostic Performance Report

diagnostic_report.pdf

Standalone stress, portfolio-context, or baseline revalidation work on an identifiable strategy or candidate.

Diagnostic evidence never substitutes for final validation and does not create a new promotion decision.

Current final-validation availability: supported paths cover qualifying US equity daily swing and CME futures daily rotation scopes. We verify the data, execution model and required evidence for each request. If a final validation is not feasible, we explain the gap; any narrower research or diagnostic scope requires your agreement.

Data terms

Missing data is scoped, never hidden.

If the hypothesis needs a feed we do not hold, availability, freshness, licensing, ingestion, normalization, and QA are checked before the declared run begins.

Standard processed

Included from $79

Existing daily OHLCV, sessions, and basic corporate actions add no data uplift.

Depth and detail

+$20–$300

Intraday, point-in-time, text, tick, or order-book evidence increases preparation and QA.

More instruments

From +$20

The uplift follows the number of instruments that must be covered, checked, and computed.

Vendor or new source

Confirmed first

Paid access is passed through visibly; a new ingestion pipeline is scoped before work.

Post-delivery monitoring

Keep the accepted baseline in view.

Monitoring compares periodic observations with the delivered baseline and posts descriptive health snapshots to the workspace. It is not live trading, a real-time SLA, or a new validation.

Plan 01

Monthly

Monitor Lite

$19/mo

One delivered strategy, monthly health snapshot, rolling metrics, and desk note.

Plan 02

Weekly

Monitor Standard

$39/mo

One delivered strategy, weekly snapshot, Watch/Decay flags, and workspace history.

Plan 03

Monthly / quarterly

Monitor Desk

$79/mo

Up to three delivered strategies, monthly snapshots, and quarterly comparison note.

Availability: offered only where fresh, comparable coverage is available for the delivered baseline.

Formal reassessment: a revalidation monitor that produces a new diagnostic report is quoted separately as a declared run.

Optional services

Add only what delivery needs.

Stress, portfolio review, and revalidation are now priced as declared run types—not add-ons. Commercial options change packaging or documented third-party cost, never the result.

Included in every report

01

Human review

$0

The declared run receives the same review discipline regardless of price or client type

Client summary

$0

A client-safe summary of up to two pages when applicable

Report QA

$0

Purpose, provenance, metrics, caveats, and evidence-boundary checks

Delivery options

02

Report walkthrough

$39–$69

A 15 or 30 minute explanation call

Second language

$49–$99

An additional translated client-facing copy

Rush delivery

+20–30%

Approximate 24h delivery when scope and capacity allow

Commercial packaging

03

Standard report use

Included

No client-type tier or automatic commercial uplift

White-label pack

$79–$149

An optional branded copy for approved third-party use

Third-party pack

$99–$249

A sanitized additional deliverable for another decision-maker

External scope

04

Commercial data licence

At documented cost

Only when the vendor requires a separate commercial-use licence

New data adapter

Quoted first

Access, ingestion, normalization, quality gates, and provenance

New strategy module

Quoted first

Reusable engine work outside the currently supported families

Feasibility check / $19

Not sure which run is valid?

We map the idea to the correct run type and report, data requirements, supported family, blockers, and exclusions before you commit to compute. The initial enquiry is free. A written feasibility check is a separate $19 service, agreed with you before any charge.

  • 01Feasibility by data and strategy family
  • 02Correct run type and report boundary
  • 03Suggested estimator configuration
  • 04Known blockers before compute
  • 05Fully credited to an eligible run purchased within 14 days

Commercial boundary

What the estimate never buys.

  • 01Calling research, candidate, or diagnostic evidence a final validation
  • 02Managed live execution or capital allocation
  • 03Buy, sell, sizing, or portfolio recommendations
  • 04A better verdict in exchange for a higher price
  • 05Unapproved vendor costs or open-ended research time

Prices are indicative and exclude applicable taxes unless stated otherwise. The signed quote confirms run intent, inputs, data availability, report, delivery, options, and exclusions before compute starts.